Company Analysis

GRAIL, Inc. (GRAL)

Nasdaq: GRAL · Services-Medical Laboratories · Menlo Park, CA · filing with the SEC since 2017
Grade5.2
◀ Past 6.9● Present 4.3▶ Future 4.8
1 est.

Who owns GRAIL, Inc.

As filed with the SEC
Holders of 5% or more
6
Baker Bros. Advisors LP holds 9.8% of Common Stock, par value $0.001 per share, as its SCHEDULE 13G/A filed May 15, 2026 says.
Directors and officers
8
report now, of 10 people on the record since 2024. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 6 named at left.
Holders of 5% or moreshare of the class, as filed
Baker Bros. Advisors LP
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, par value $0.001 per share · 5.3% in Feb 17, 2026
9.8%
Farallon Capital Management, L.L.C.
SCHEDULE 13G/A · filed Aug 13, 2026 · Common Stock, par value $0.001 per share (the "Shares")
9.6%
Blackrock, Inc.
SCHEDULE 13G/A · filed Jul 28, 2026 · Common Stock · 6.5% in Jul 17, 2025
7.9%
Dapice Joshua J.
SCHEDULE 13G/A · filed May 11, 2026 · Common Stock, par value $0.001 per share (the "Shares") · 5.9% in Feb 9, 2026
7.8%
State Street Corporation
5.6%
Primecap Management Co/ca/
SCHEDULE 13G/A · filed Aug 6, 2026 · COM · 4.72% in Feb 11, 2026
5.08%
Crcm LP
SCHEDULE 13G/A · filed Oct 6, 2025 · Common Stock, par value $0.001 · reported falling below 5%, from 5.11% in Oct 3, 2025
under 5%
Sessa Capital (Master), L.P.
SCHEDULE 13G/A · filed May 7, 2025 · Common Stock, $0.001 par value · reported falling below 5%
under 5%
Illumina, Inc.
SCHEDULE 13G/A · filed Feb 17, 2026 · Common Stock, $0.001 par value · reported falling below 5%
under 5%
The Vanguard Group
SCHEDULE 13G/A · filed Mar 27, 2026 · Common Stock · reported falling below 5%, from 5.28% in Jul 29, 2025
under 5%
What GRAL reports owning in othersstakes of 5% or more, and other ties
GRAIL, Inc. reports no stake in another company in the record.
Insider tradesForm 4
47sales
0purchases
19sales on a scheduled plan
4people selling
$38.1Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Oct 16, 2025 to Oct 16, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
242526
2026 runs to Oct 16, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window5 of 12 on the roster
PersonRole as filedSalesSoldOn a planBuysBought
Illumina, Inc.10% owner1$79.9M00$0
Ofman Joshua J.Chief Executive Officer23$15.1M160$0
Ragusa Robert PChief Executive Officer10$12.3M00$0
Freidin AaronChief Financial Officer13$10.0M40$0
Partridge Andrew JohnChief Growth Officer2$1.2M00$0
SI Assistanton GRAL · research, not advice